176 related articles for article (PubMed ID: 22475628)
21. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
22. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.
Ge P; Yu X; Wang ZC; Lin J
Asian Pac J Cancer Prev; 2015; 16(9):4071-5. PubMed ID: 25987089
[TBL] [Abstract][Full Text] [Related]
23. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
24. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
[TBL] [Abstract][Full Text] [Related]
25. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
26. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
27. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
[TBL] [Abstract][Full Text] [Related]
28. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
[No Abstract] [Full Text] [Related]
29. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
30. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
[TBL] [Abstract][Full Text] [Related]
31. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
32. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
Ta L; Xuan C; Xing N; Zhu X
Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer.
Datta K; Li J; Bhattacharya R; Gasparian L; Wang E; Mukhopadhyay D
Cancer Res; 2004 Jan; 64(2):456-62. PubMed ID: 14744756
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
35. Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma.
Furuya N; Kamai T; Shirataki H; Yanai Y; Fukuda T; Mizuno T; Nakamura F; Kambara T; Nakanishi K; Abe H; Yoshida K
Cancer Immunol Immunother; 2011 Jun; 60(6):793-808. PubMed ID: 21350947
[TBL] [Abstract][Full Text] [Related]
36. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
38. Alteration of apoptotic regulatory molecules expression during carcinogenesis and tumor progression of renal cell carcinoma.
Sejima T; Isoyama T; Miyagawa I
Int J Urol; 2003 Sep; 10(9):476-84. PubMed ID: 12941126
[TBL] [Abstract][Full Text] [Related]
39. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of ST3Gal IV expression in human renal cell carcinoma.
Saito S; Yamashita S; Endoh M; Yamato T; Hoshi S; Ohyama C; Watanabe R; Ito A; Satoh M; Wada T; Paulson JC; Arai Y; Miyagi T
Oncol Rep; 2002; 9(6):1251-5. PubMed ID: 12375029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]